James Reuben

Scientific Advisor at ANGLE

Dr. Reuben is a Professor in the Department of Hematopathology, Division of Pathology/Lab Medicine at The University of Texas MD Anderson Cancer Center, Houston, Texas. Dr. Reuben is a leading authority and has conducted significant research on circulating tumour cell subsets, including those with epithelial and mesenchymal phenotypes and their clinical relevance to minimal residual disease in breast cancer.

Some related publications include “Circulating tumor cells, disease progression, and survival in metastatic breast cancer in the New England Journal of Medicine”; “Circulating tumor cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients” in the British Journal of Cancer; and “Circulating tumor cells in metastatic inflammatory breast cancer” published in the Annals of Oncology. Dr. Reuben received his PhD in immunology from McGill University in Montreal, Canada and his MBA from University of Houston, Houston, Texas. Dr. Reuben completed his research fellowship in the Department of Experimental Therapeutics at The University of Texas MD Anderson Cancer Center with Evan M. Hersh, MD and Emil J Freireich, MD, as mentors.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


ANGLE

ANGLE is a world-leading liquid biopsy company. Their Parsortix® technology enables the capture and harvest of viable circulating tumor cells (CTCs) from patient blood.


Industries

Employees

51-200

Links